Tag - gene therapy

Markets

Janney starts Applied Genetic Technologies at buy; fair value estimate $13

Janney initiated coverage of Applied Genetic Technologies (NASDAQ:AGTC) with a “buy” rating and fair value estimate of $13. The stock closed at $3.20 on Sept. 5. “We see a highly attractive investment opportunity in...

September 6, 2019

Developments

Abeona reports positive interim data from Phase 1/2 gene therapy trial

Abeona Therapeutics (NASDAQ:ABEO) reported positive data from its ongoing Phase 1/2 clinical trial of ABO-102 for the treatment of Sanfilippo syndrome type A (MPS IIIA). Primarily affecting the central nervous system...

July 25, 2019

Tag - gene therapy

Janney starts Applied Genetic Technologies at buy; fair value estimate $13

Abeona reports positive interim data from Phase 1/2 gene therapy trial

General

More